Skip to Content

C 517 (Darifenacin Hydrobromide Extended-Release 15 mg)

Pill with imprint C 517 is Peach, Round and has been identified as Darifenacin Hydrobromide Extended-Release 15 mg. It is supplied by Jubilant Cadista Pharmaceuticals Inc..

Darifenacin is used in the treatment of urinary frequency; overactive bladder; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darifenacin 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C 517

Darifenacin Hydrobromide Extended-Release

Imprint
C 517
Strength
15 mg
Color
Peach
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Urinary antispasmodics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Jubilant Cadista Pharmaceuticals Inc.
National Drug Code (NDC)
59746-0517
Inactive Ingredients
calcium phosphate dibasic anhydrous, hypromelloses, magnesium stearate, polyethylene glycol, magnesium silicate, titanium dioxide, ferric oxide red, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "C 517"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.